Musclepharm (MSLP) Inventory Turnover Ratio, from first quarter 2022 to first quarter 2021, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Musclepharm Corporation  (MSLP)
 

Musclepharm Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Musclepharm Corporation inventory turnover ratio, the Musclepharm Corporation's ability to sell and replace its inventory in the first quarter 2022, sequentially increased to 31.46 in the first quarter 2022, MSLP's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Musclepharm in Mar 31 2022 quarter, has decreased to 12 days, compare to 13 days, in the Dec 31 2021 quarter.

Within Healthcare sector 10 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2022, to 159, from total ranking in the fourth quarter 2021 at 177.

MSLP Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Musclepharm Corporation Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MSLP Inventory Turnover Ratio (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter
Y / Y Inventory Growth -27.94 % 77.33 % 6.86 % -69.51 % -72.81 %
Y / Y Cost of Sales Growth 22.9 % 2.34 % 7.85 % 5.99 % -17.42 %
Inventory Turnover Ratio (TTM) 31.46 28.21 32.11 32.07 19.06
MSLP's Total Ranking # 159 # 177 # 155 # 157 # 158
Average inventory processing period 12 13 11 11 19
Seq. Inventory Growth -46.72 % 15.17 % 1.79 % 15.37 % 31.1 %
Seq. Cost of Sales Growth 9.68 % -11.5 % -6.18 % 34.94 % -8.67 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 5
Healthcare Sector # 11
Overall Market # 159

Inventory Turnover Ratio Statistics
High Average Low
167.69 18.98 5.89
(Mar 31 2013)   (Mar 31 2015)



MSLP Company Profile >> Back to MSLP Efficiency Comparisons >> Compare MSLP Inventory Turnover Ratio to its Competitors

Financial Statements
Musclepharm's Inventories $ 1 Millions Visit MSLP's Balance sheet
Musclepharm's Cost of Revenues TTM $ 47 Millions Visit MSLP's Income Statement
What are MSLP's Sales? Visit MSLP's Sales by Segment

Other Inventory Turnover Ratios
Musclepharm's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
MSLP's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for MSLP's Competitors
Inventory Turnover Ratio for MSLP's Suppliers
Inventory Turnover Ratio for MSLP's Customers

You may also want to know
MSLP's Sales Growth Rates MSLP's Pe Price to earnings ratio MSLP's Receivables Turnover Ratio MSLP's Stock Quote
MSLP's Net Income Growth Rates MSLP's Ps Price to Sales ratio MSLP's Sales per Employee MSLP's Asset Turnover Ratio
MSLP's Net Margin MSLP's Pb Price to Book ratio MSLP's Financial Strength Ratios MSLP's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2022, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2022 Inventories at quarter ending Mar 31 2022
REST EZ Inc.  103.50 $ 0.269  Millions$ 0  Millions
Avalo Therapeutics Inc   86.22 $ 2.134  Millions$ 0  Millions
1life Healthcare Inc   61.33 $ 349.924  Millions$ 6  Millions
Healthcare Services Group Inc   55.01 $ 1,451.725  Millions$ 26  Millions
Quest Diagnostics Inc  32.63 $ 6,599.000  Millions$ 202  Millions
Scienture Holdings Inc   31.72 $ 4.474  Millions$ 0  Millions
Uphealth Inc   31.62 $ 100.208  Millions$ 3  Millions
Musclepharm Corporation  31.46 $ 46.831  Millions$ 1  Millions
Intelgenx Technologies Corp   30.07 $ 2.105  Millions$ 0  Millions
Biocept Inc   26.57 $ 40.066  Millions$ 2  Millions
Clene Inc   26.31 $ 1.138  Millions$ 0  Millions
Labcorp Holdings Inc   25.33 $ 10,600.800  Millions$ 419  Millions
Aspira Women s Health inc   25.22 $ 3.789  Millions$ 0  Millions
Vanda Pharmaceuticals Inc   23.66 $ 25.264  Millions$ 1  Millions
U s Stem Cell Inc   23.01 $ 0.044  Millions$ 0  Millions
Vaso Corporation  22.76 $ 31.728  Millions$ 1  Millions
Dermtech Inc   22.40 $ 12.116  Millions$ 1  Millions
Adapthealth Corp   21.87 $ 2,209.349  Millions$ 101  Millions
Viemed Healthcare Inc   17.94 $ 45.490  Millions$ 3  Millions
Evolus Inc   16.55 $ 51.834  Millions$ 3  Millions
Rennova Health Inc   15.09 $ 5.070  Millions$ 0  Millions
Option Care Health Inc   14.56 $ 2,780.118  Millions$ 191  Millions
Rockwell Medical inc   14.18 $ 64.928  Millions$ 5  Millions
Lifemd Inc   13.03 $ 19.732  Millions$ 2  Millions
Harmony Biosciences Holdings inc   12.74 $ 59.825  Millions$ 5  Millions
Natera Inc   12.67 $ 343.300  Millions$ 27  Millions
Cannabis Global Inc.  11.83 $ 2.633  Millions$ 0  Millions
Precipio inc   11.79 $ 6.845  Millions$ 1  Millions
Infusystem Holdings Inc  11.47 $ 43.694  Millions$ 4  Millions
Myriad Genetics Inc   11.29 $ 189.600  Millions$ 17  Millions

Date modified: 2026-08-29T17:19:05+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.